Wed, Mar 4, 2015, 3:37 AM EST - U.S. Markets open in 5 hrs 53 mins


% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • sknbmc sknbmc May 10, 2013 12:29 PM Flag

    Switzerland: Belviq's Gateway to the EU Market


    If Belviq's approval chances are better in Switzerland, the product will still be available to Europeans without EMA approval. Let the EMA drag its feet. People who want the product will be able to get it, in person, by mail or online. On top of that, the pill is produced in Switzerland! (by VPInvestor from ivboard)

    EU residents flock to Switzerland to fill prescriptions

    European Union residents struggling to get the medication they need are increasingly turning to Switzerland for their supply. It’s because a number of pharmaceutical companies have stopped supplies to European countries which can’t pay their bills. The impact of austerity measures means that people from countries like Greece, Spain and Portugal are heading to pharmacies while they’re in Switzerland. Residents of France, the UK and Austria are also making the journey because of national restrictions on things like the amount of a drug you can buy. Lorenz Schmid is the president of the Zurich Pharmacists’ Association. He told WRS’s Catherine Allen that exchange rates also come into play:

    Sentiment: Strong Buy

    This topic is deleted.
4.04-0.24(-5.61%)Mar 3 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.